Evidence map›Paper›PMID 21503604›Full record

ArticlePsychopharmacology2011

The use of healthy volunteers instead of patients to inform drug dosing studies: a [¹¹C]raclopride PET study.

Euitae Kim, Oliver D Howes, Bo-Hyung Kim, Kyung-Sang Yu, Jae Min Jeong, Jae Sung Lee, Su Jin Kim, In-Jin Jang, Jung Shin Park, Yong Gil Kim and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Euitae KimDepartment of Psychiatry, Seoul National University College of Medicine, 28 Yeongon-dong, Chongno-gu, Seoul 110-744, South Korea.
Oliver D Howes
Bo-Hyung Kim
Kyung-Sang Yu
Jae Min Jeong
Jae Sung Lee
Su Jin Kim
In-Jin Jang
Jung Shin Park
Yong Gil Kim
Sang-Goo Shin
Federico E Turkheimer
Shitij Kapur
Jun Soo Kwon

Funding

Medical Research Council G0700995Medical Research Council MC_U120085814Medical Research Council MC_U120097115
6 · The paper itself

Abstract

rationaleReceptor occupancy study has been performed to evaluate pharmacokinetic profiles in new antipsychotic drug development. While these findings highlight the value of positron emission tomography (PET) for dose-finding study, what is unclear is if it is necessary to conduct these studies in patients with schizophrenia or whether studies in healthy volunteers are adequate.

objectivesTo determine if it is necessary to conduct dopamine receptor occupancy studies in patients with schizophrenia or whether studies in healthy volunteers are adequate for dose-finding study, we compared the concentration-occupancy relationship in terms of EC(50) between patients and healthy volunteers.

methodsTen healthy volunteers and eight patients with schizophrenia participated in the study. We measured dopamine receptor occupancy using [(11)C]raclopride PET and plasma concentration of YKP1358, a novel antipsychotic drug under clinical development, at a number of time points after the administration of YKP1358. Pharmacokinetic data including area under the plasma concentration versus time curve, elimination half-life, maximum observed plasma concentration, and the time to reach the maximum observed plasma concentration were obtained. We explored the relationship between plasma concentration and dopamine D(2) receptor occupancy using E (max) model and calculated EC(50).

resultsThe elimination half-life was longer in healthy volunteers than in patients. Other pharmacokinetic parameters were not significantly different between two groups. The EC(50) was 7.6 ng/ml (95% confidence interval (CI) 6.2-9.0) in healthy volunteers and 8.6 (95% CI 7.4-9.9) in patients.

conclusionsThe antipsychotic concentration-occupancy relationship in patients can be estimated from the EC(50) data of healthy volunteers.

Indexed as

Patient SelectionAdultAlkaloidsAntipsychotic AgentsBinding, CompetitiveCarbon RadioisotopesClinical Trials as TopicData Interpretation, StatisticalDopamine D2 Receptor AntagonistsDose-Response Relationship, DrugFemaleHalf-LifeHumansMaleMiddle AgedModels, BiologicalAlkaloidsAntipsychotic AgentsCarbon RadioisotopesDopamine D2 Receptor AntagonistsRacloprideReceptors, Dopamine D2Receptor, Serotonin, 5-HT2AYKP 1358

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.